Citigroup’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-30,000
Closed -$8.23M 6187
2021
Q2
$8.23M Buy
+30,000
New +$8.15M 0.01% 1547
2020
Q4
Sell
-100
Closed -$24K 7566
2020
Q3
$24K Sell
100
-5,400
-98% -$1.14M ﹤0.01% 6056
2020
Q2
$1.07M Sell
5,500
-6,600
-55% -$1.26M ﹤0.01% 3494
2020
Q1
$2M Sell
12,100
-12,300
-50% -$2.25M ﹤0.01% 2475
2019
Q4
$4.18M Buy
24,400
+6,700
+38% +$1.12M ﹤0.01% 2184
2019
Q3
$2.92M Buy
17,700
+15,000
+556% +$2.11M ﹤0.01% 2453
2019
Q2
$322K Buy
2,700
+400
+17% +$41K ﹤0.01% 4857
2019
Q1
$219K Buy
2,300
+200
+10% +$17.1K ﹤0.01% 5006
2018
Q4
$167K Buy
2,100
+1,800
+600% +$152K ﹤0.01% 5204
2018
Q3
$32K Buy
+300
New +$28.1K ﹤0.01% 6851

Other funds holding PODD

Citigroup's PODD Position: Q1 2026 in Review

Citigroup reduced its Insulet (PODD) stake by 30% in Q1 2026, selling an estimated $7.23M and leaving 66,493 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #1270.

Citigroup first reported a position in PODD in Q2 2013 and has held it in 51 quarters since. The position peaked at $27.7M in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Citigroup held 66,493 shares of Insulet worth $14M as of Q1 2026.
  • Citigroup sold 28,759 Insulet shares in Q1 2026, an estimated $7.23M.
  • Insulet made up 0.01% of Citigroup's portfolio in Q1 2026, its #1270 holding.
  • Citigroup first reported a position in Insulet in Q2 2013 and has held it in 51 quarters since.
  • Citigroup's Insulet position peaked at $27.7M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.